Ditsch N

No ORCID on file · 3 papers in corpus
2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-2073-1887

In patients with existing ovarian function, there are some special aspects to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-negative (HR pos./HER2 neg.) breast cancer. Treatment options include ta…

2020
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-020-03241-7

PurposeThyroid hormone receptors (THR) have manifold functions and are involved in the carcinogenesis of several tumor types. Within this study, we aimed to investigate the expression pattern (nuclear versus cytoplasmic) of the THR alpha an…

2012
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.
BMC cancer ·doi:10.1186/1471-2407-12-2

BackgroundAn influence of gonadotropins (hCG) on the development of ovarian cancer has been discussed. Therefore, we quantified serum hCG levels in patients with benign and malignant ovarian tumors and the hCG expression in ovarian cancer t…